Similarly, the expression levels of TRIB3, RRM2, NT5DC2, and CISD1 increased with the clinical stages of HCC (Figure 4E), while TF and ALB displayed the opposite trend. Here, NT5DC2 is linked to hepatocellular carcinoma.